See also this year's filing and all EDGAR filings for this company.
PDF Report 0001817713_2023_Janux_Therapeutics_Inc.pdf
Logs
Graph
Absolute values for 0001817713, Janux Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 332,439,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 7,086,000 |
| 3 | remainder_Assets | 24,485,000 |
| 4 | LiabilitiesCurrent | 16,507,000 |
| 5 | LiabilitiesNoncurrent | 26,763,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 22,262,000 |
| 9 | ResearchAndDevelopmentExpense | 53,441,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 8,612,000 |
| 12 | remainder_NetIncome | 4,032,000 |
| 13 | remainder_ComprehensiveNetIncome | -1,265,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 364,010,000 |
| 1 | Liabilities | 43,270,000 |
| 2 | Expenses | 75,703,000 |
| 3 | Revenues | 8,612,000 |
| 4 | StockholdersEquity | 320,740,000 |
| 5 | NetIncome | -63,059,000 |
| 6 | ComprehensiveNetIncome | -63,691,500 |
| 7 | BaseVar | 248,446,000 |
| 8 | EconomicCapitalRatio | 2.40 |